Monthly Archives: October 2011

The Rise of the Patient: Medicine 2.0

By Guest Blogger | Published: October 12, 2011
by Sarah Krüg Amidst yellow sandstone arches and California Mission Revival architecture, The Medicine 2.0 +Stanford Summit (otherwise known as the Fourth World Congress on Social Media and Web 2.0 in Health Medicine) set out on a three day journey to challenge its diverse audience to break down silos and expand beyond traditional boundaries. From a [...]
Posted in Meetings, Patient Communication, Strategy, Technology, healthcare, leadership, patient compliance, patient education, social media | Tagged , | Leave a comment

Medco CEO Champions Robots Over Pharmacists

By Ben Comer | Published: October 11, 2011
The role of the pharmacist in positive health outcomes – and drug company profits – is often cited in discussions around adherence to medication regimens, holistic prescribing practices and the navigation of insurance payment structures. In an attempt to demystify that role, Medco CEO David Snow told attendees at the Cleveland Clinic’s Medical Innovation Summit last [...]
Posted in Regulatory, Strategy, patient education, pricing | Tagged , , , , | 22 Comments

Pfizer CEO: DTC a 'Fundamental Right'

By Ben Comer | Published: October 5, 2011
Direct-to-consumer (DTC) advertising is a “fundamental right in the U.S.,” and denying the right of industry to speak directly to patients through drug advertising “leads to ignorance and the inability to judge,” said Ian Read, Pfizer’s president and CEO, at the Cleveland Clinic on Tuesday. Asked whether DTC ads on television should be retired, Read answered [...]
Posted in Advertising, IP, Marketing, Patient Communication, Regulatory, Strategy, leadership, patient education | Tagged , | 7 Comments

European Pharma 1981-2011: Survival of the Fittest?

By Guest Blogger | Published: October 5, 2011
This month sees Pharmaceutical Executive magazine reach its 30th birthday. In line with that milestone, Reflector assesses what the last three decades have meant for European pharma — and shows how the game has changed beyond recognition. Thirty years is a long time in any industry. The coalmining industry, the market for air travel, or telecommunications [...]
Posted in Emerging Markets, Europe, Global, Guest Blog, IP, Pharm Exec Magazine, R&D, Regulatory, healthcare, leadership | Tagged , , , , , , | Leave a comment

Prix Galien Winners Embody Innovation

By Jennifer Ringler | Published: October 4, 2011
The winners of the fifth annual Prix Galien USA represent the progress of the entire industry and show us how far we’ve come in advancing the pace of innovation and commercializing new medicines that save lives and improve standard of care. Pharmaceutical Executive served as a lead media partner for the 2011 Prix Galien awards, held [...]
Posted in Events | Tagged , , | Leave a comment